161 related articles for article (PubMed ID: 1927117)
1. [The treatment of oligozoospermia with tamoxifen does not improve sperm quality].
Sterzik K; Rosenbusch B; Grab D; Heyden M; Lichtenberger K; Wolf A
Zentralbl Gynakol; 1991; 113(12):683-8. PubMed ID: 1927117
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen treatment of oligozoospermia: a re-evaluation of its effects including additional sperm function tests.
Sterzik K; Rosenbusch B; Mogck J; Heyden M; Lichtenberger K
Arch Gynecol Obstet; 1993; 252(3):143-7. PubMed ID: 8503705
[TBL] [Abstract][Full Text] [Related]
3. Treatment of idiopathic oligozoospermia with tamoxifen.
Brigante C; Motta G; Fusi F; Coletta MP; Busacca M
Acta Eur Fertil; 1985; 16(5):361-4. PubMed ID: 3936325
[TBL] [Abstract][Full Text] [Related]
4. Correlation between follicle-stimulating hormone, luteinizing hormone, prolactin, and testosterone with sperm cell concentration and motility.
Vasquez JM; Ben-Nun I; Greenblatt RB; Mahesh VB; Keel BA
Obstet Gynecol; 1986 Jan; 67(1):86-90. PubMed ID: 3079622
[TBL] [Abstract][Full Text] [Related]
5. [A hormone assay as a therapeutic choice in male sterility].
Avril-Ducarne C; Kuhn JM; Cossec A; Bastit P; Bisson JP; Wolf LM
J Gynecol Obstet Biol Reprod (Paris); 1990; 19(7):881-8. PubMed ID: 2126018
[TBL] [Abstract][Full Text] [Related]
6. [Long-term therapy of oligozoospermia with the aromatase inhibitor testolactone].
Schill WB; Reiter F; Korting HC; Schweikert HU
Hautarzt; 1987 Jul; 38(7):395-9. PubMed ID: 3115914
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic results with tamoxifen in oligospermia. II. Hormonal analysis and semen parameters].
Schieferstein G; Adam W; Armann J; Bantel E; Cörlin R; Egenrieder H; Fierlbeck G; Hook B; Schiek A; Schubring G
Andrologia; 1987; 19(3):333-41. PubMed ID: 3115143
[TBL] [Abstract][Full Text] [Related]
8. The beneficial effects of toremifene administration on the hypothalamic-pituitary-testicular axis and sperm parameters in men with idiopathic oligozoospermia.
Farmakiotis D; Farmakis C; Rousso D; Kourtis A; Katsikis I; Panidis D
Fertil Steril; 2007 Oct; 88(4):847-53. PubMed ID: 17412336
[TBL] [Abstract][Full Text] [Related]
9. Relationships between serum hormone levels and semen quality among men from an infertility clinic.
Meeker JD; Godfrey-Bailey L; Hauser R
J Androl; 2007; 28(3):397-406. PubMed ID: 17135633
[TBL] [Abstract][Full Text] [Related]
10. Androgens in seminal plasma: markers of the surface epithelium of the male reproductive tract.
Zalata A; Hafez T; Verdonck L; Vermeulen L; Comhaire F
Int J Androl; 1995 Oct; 18(5):271-7. PubMed ID: 8567098
[TBL] [Abstract][Full Text] [Related]
11. Hormonal changes in tamoxifen treated men with idiopathic oligozoospermia.
Hampl R; Heresová J; Lachman M; Sulcová J; Stárka L
Exp Clin Endocrinol; 1988 Dec; 92(2):211-6. PubMed ID: 3243340
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen citrate therapy in male infertility.
AinMelk Y; Belisle S; Carmel M; Jean-Pierre T
Fertil Steril; 1987 Jul; 48(1):113-7. PubMed ID: 3297810
[TBL] [Abstract][Full Text] [Related]
13. [The effects of tamoxifen on the hormones and the sperm in 80 oligospermic and asthenospermic men].
Buvat J; Gauthier A; Ardaens K; Buvat-Herbaut M; Lemaire A
J Gynecol Obstet Biol Reprod (Paris); 1982; 11(3):407-15. PubMed ID: 6811649
[No Abstract] [Full Text] [Related]
14. [Experiences with the antiestrogen tamoxifen in the therapy of oligozoospermia].
Schill WB; Landthaler M
Hautarzt; 1981 Jun; 32(6):306-8. PubMed ID: 7263237
[TBL] [Abstract][Full Text] [Related]
15. Recombinant-growth hormone (rec-hGH) therapy in infertile men with idiopathic oligozoospermia.
Radicioni A; Paris E; Dondero F; Bonifacio V; Isidori A
Acta Eur Fertil; 1994; 25(5):311-7. PubMed ID: 7660721
[TBL] [Abstract][Full Text] [Related]
16. Treatment of male idiopathic infertility with recombinant human follicle-stimulating hormone: a prospective, controlled, randomized clinical study.
Foresta C; Bettella A; Garolla A; Ambrosini G; Ferlin A
Fertil Steril; 2005 Sep; 84(3):654-61. PubMed ID: 16169399
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of CYP2D6*10 and the effectiveness of combined tamoxifen citrate and testosterone undecanoate treatment in infertile men with idiopathic oligozoospermia.
Tang KF; Zhao YL; Ding SS; Wu QF; Wang XY; Shi JQ; Sun F; Xing JP
J Zhejiang Univ Sci B; 2015 Mar; 16(3):191-7. PubMed ID: 25743120
[TBL] [Abstract][Full Text] [Related]
18. [Systemic therapy of male subfertility].
Maier U
Wien Klin Wochenschr; 1989 Oct; 101(19):673-9. PubMed ID: 2618055
[TBL] [Abstract][Full Text] [Related]
19. Role of testosterone/estradiol ratio in predicting the efficacy of tamoxifen citrate treatment in idiopathic oligoasthenoteratozoospermic men.
Cakan M; Aldemir M; Topcuoglu M; Altuğ U
Urol Int; 2009; 83(4):446-51. PubMed ID: 19996653
[TBL] [Abstract][Full Text] [Related]
20. Endocrine effects of testosterone undecanoate as a supplementary treatment to menopausal gonadotropins or tamoxifen citrate in idiopathic oligozoospermia.
Adamopoulos DA; Nicopoulou S; Kapolla N; Vassilopoulos P; Karamertzanis M; Kontogeorgos L
Fertil Steril; 1995 Oct; 64(4):818-24. PubMed ID: 7672156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
